ProfileGDS4718 / 65517_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 93% 70% 94% 92% 89% 92% 92% 93% 93% 93% 91% 94% 90% 92% 92% 94% 91% 93% 82% 92% 93% 93% 94% 93% 92% 93% 88% 93% 94% 92% 88% 92% 94% 92% 89% 90% 91% 92% 57% 94% 92% 88% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.112294
GSM549102patient 115, normal, homogenized [OPG study]9.7375493
GSM549104patient 119, normal, homogenized [OPG study]6.8910970
GSM549108patient 138, normal, homogenized [OPG study]9.869494
GSM549119patient 077, normal, homogenized [OPG study]9.5999292
GSM549133patient 032, cancer, homogenized [OPG study]9.2003889
GSM549139patient 042, cancer, homogenized [OPG study]9.5726492
GSM549099patient 107, normal, homogenized [OPG study]9.6087592
GSM549109patient 139, normal, homogenized [OPG study]9.7233493
GSM549110patient 046, normal, homogenized [OPG study]9.8520493
GSM549114patient 063, normal, homogenized [OPG study]9.9781593
GSM549122patient 082, normal, homogenized [OPG study]9.4132891
GSM549134patient 033, cancer, homogenized [OPG study]9.8626894
GSM549136patient 036, cancer, homogenized [OPG study]9.3279690
GSM549140patient 044, cancer, homogenized [OPG study]9.5725492
GSM549111patient 047, normal, homogenized [OPG study]9.7076192
GSM549113patient 057, normal, homogenized [OPG study]10.131794
GSM549132patient 031, cancer, homogenized [OPG study]9.3972191
GSM549137patient 038, cancer, homogenized [OPG study]9.6830693
GSM549142patient 047, cancer, homogenized [OPG study]7.8107182
GSM549100patient 110, normal, homogenized [OPG study]9.6445992
GSM549107patient 135, normal, homogenized [OPG study]9.933593
GSM549115patient 068, normal, homogenized [OPG study]10.058493
GSM549116patient 072, normal, homogenized [OPG study]9.9822494
GSM549120patient 078, normal, homogenized [OPG study]9.7195793
GSM549131patient 030, cancer, homogenized [OPG study]9.6131692
GSM549118patient 074, normal, homogenized [OPG study]9.84493
GSM549129patient 027, cancer, homogenized [OPG study]8.8173988
GSM549123patient 088, normal, homogenized [OPG study]9.9359993
GSM549124patient 006, cancer, homogenized [OPG study]9.7132394
GSM549126patient 015, cancer, homogenized [OPG study]9.4522392
GSM549128patient 025, cancer, homogenized [OPG study]8.9043288
GSM549103patient 117, normal, homogenized [OPG study]9.4816892
GSM549117patient 073, normal, homogenized [OPG study]10.172994
GSM549138patient 041, cancer, homogenized [OPG study]9.5308592
GSM549141patient 045, cancer, homogenized [OPG study]9.1471389
GSM549130patient 028, cancer, homogenized [OPG study]9.0635690
GSM549101patient 111, normal, homogenized [OPG study]9.3128891
GSM549105patient 128, normal, homogenized [OPG study]9.5779792
GSM549106patient 134, normal, homogenized [OPG study]5.897657
GSM549112patient 048, normal, homogenized [OPG study]10.142894
GSM549125patient 011, cancer, homogenized [OPG study]9.3844892
GSM549127patient 024, cancer, homogenized [OPG study]8.7808688
GSM549135patient 035, cancer, homogenized [OPG study]9.4949691